Jaguar Health, Inc. (JAGX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. on August 19, 2026. The filing serves to announce the Company's financial results for the second quarter of 2026. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market under the symbol "JAGX".
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The filing references a press release (Exhibit 99.1) containing the detailed second quarter 2026 results, but the text of that press release is not included in the source data.
Material Changes
No material changes versus the prior comparable period can be summarized as the source text does not provide comparative financial data or specific operational updates beyond the announcement of the results.
Guidance, Outlook, and Risks
The filing does not include specific guidance, outlook, management commentary, risks, contingencies, or unusual items. It explicitly states that the information in Item 2.02 and the accompanying press release shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific Q2 2026 revenue, net loss, and cash position figures.
- Verify the Company's liquidity status and runway based on the detailed financial statements referenced in the press release.
- Check for any forward-looking statements or updated guidance provided in the full press release text.
- Confirm the status of the Company's emerging growth company designation and any related accounting transitions.